Why submit your abstract(s) to ISCT 2022?

  • Global networking.  Discuss your research with global leaders in translation science.
  • Publish your work.  Accepted abstracts will be published in a special supplement of Cytotherapy, and many studies first presented at ISCT Annual Meetings go on to be published as full-length articles.
  • Present your research.  Authors of outstanding abstracts will have the opportunity to present Oral Abstracts and Elevator Pitch presentations in San Francisco.

Key Dates

  • Submissions Open: October 11, 2021
  • Submission Deadline: January 17, 2022
  • Notifications of Acceptance: February 15, 2022

Publication and Fees

Accepted abstracts will be published in a supplemental version of Cytotherapy, the official journal of ISCT. 
There are no fees associated with submitting an abstract.  Those presenting abstracts will be responsible for their own registration expenses.  

Abstract Categories

  • Mesenchymal Stem/Stromal Cells
  • Hematopoietic Stem/Progenitor Cells and Engineering
  • Immunotherapy
  • Exosomes/EVs
  • iPSC
  • Gene Editing/Gene Therapy
  • Tissue Engineering
  • Embryonic, Organ and Other Tissue Specific Stem Cells
  • Process Development and Manufacturing
  • Regulator Affairs, Quality Systems, Policy and Ethics

Full List of Abstract Categories


  • Top Scoring Abstract Award ($1500 USD)
  • Best Poster Award ($1500 USD) Sponsored by BioCanRx
  • Early Stage Professionals Awards ($1000 USD)
    • 3 available
  • Technologist Awards ($1000 USD)
    • 3 available
  • Top Scoring Emerging Economies Abstract Award ($1,000 USD) – Sponsored by Cytotherapy
  • ESP Rookie of the Year Award ($500 USD) – Sponsored by Cytotherapy

Eligibility Criteria: Individuals must hold an active ISCT Membership

Guidelines and Policies

  • The abstract body cannot exceed 2500 characters, exclusive of the title, author block, images, and tables
  • Note that spaces count as characters
  • Abstracts must be submitted via the online Abstract Submission System. Abstracts will NOT be accepted by email, mail, or fax
  • ISCT may reject abstracts that are considered inappropriate for any reason. Abstracts, once submitted, can only be withdrawn from publication no later than February 28, 2022. If not withdrawn by this deadline, All accepted abstracts will be published in the final program and abstract supplement
  • Abstract presenters MUST be registered for the meeting. For those requiring acceptance notifications before registering, ISCT 2022 will allow up to two weeks after acceptance for these individuals to register
  • Abstracts submitted to the ISCT 2022 Annual Meeting are embargoed from the time of submission.
  • For the abstract to be eligible for presentation at the ISCT 2022 Annual Meeting, information contained within, as well as additional data and information to be presented about the content, may not be published elsewhere or made public before the abstract has been published/presented at the ISCT 2022 Annual Meeting.
  • Authors must notify ISCT 2022 if, after the submission deadline, the submitted abstract is accepted for publication elsewhere and will be published before the ISCT 2022 Annual Meeting. Publication before the meeting may result in the abstract being removed from the conference.
  • If the Embargo Policy is violated, the abstract may be withdrawn by ISCT 2022 from presentation at the ISCT 2022 Annual Meeting and from publication in the abstract supplement.

*An embargo means that information from any abstract or presentation may not be announced,
publicized, or distributed before the embargo date and time.